Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-03-14
2006-03-14
Meller, Michael (Department: 1655)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07012062
ABSTRACT:
Use of modified lysozyme c or its pharmaceutically acceptable salts and its industrial production for the preparation of medicinal compositions, suitable for oral, parenteral and topical administration, for prophylaxis and therapy of diseases in mammals.
REFERENCES:
patent: 5382657 (1995-01-01), Karasiewicz et al.
patent: 5711944 (1998-01-01), Gilbert et al.
patent: 5880255 (1999-03-01), Delgado et al.
patent: 5908621 (1999-06-01), Glue et al.
patent: 6177074 (2001-01-01), Glue et al.
patent: 94/01127 (1994-01-01), None
Takada et al, “Binding of Lysozyme to Lipopolysaccharide . . . ,” Infection and Immunity, vol. 62, No. 4, pp. 1171-1175 (1994).
Sava et al, “Mechanism of the Antieoplastic Action of Lysozyme . . . ,” Anticancer Research, vol. 9, pp. 1175-1180 (1989).
So et al, “Reduced immunogenicity of monomethyoxypolyethylene . . . ,” Immunology Letters, vol. 49, p. 91-97 (1996).
Pacor et al, “Antimetastatic Action and Lymphocyte Activation . . . ,” Anticancer Research, vol. 16, pp. 2559-2564 (1996).
Protein Homology Search (Swiss-Prot); Oct. 13, 1995; 2pp.
Yuji Inada et al; “Application of polyethylene glycol-modified enzymes in biotechnological processes: organic solvent-soluble enzymes”; TIBTECH; Jul. 1986; pp. 190-194.
Yuji Inada et al; “Biomedical and biotechnological applications of PEG- and PM-modified proteins”; TIBTECH; Mar. 1995 (vol. 13); pp. 86-91.
Francesco M. Veronese; “Peptide and protein PEGylation: a review of problems and solutions”; Biomaterials; 22 (2001); Elsevier Science Ltd.; pp. 405-417.
Rodriguez Paolo E. A.
Veronesi Paolo Alberto
Buchanan Ingersoll, P.C
Meller Michael
Therapicon SRL
LandOfFree
Use of modified lysozyme C to prepare medicinal compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of modified lysozyme C to prepare medicinal compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of modified lysozyme C to prepare medicinal compositions... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3599285